7630 — IMPACT Therapeutics Share News
0.000.00%
Last trade - 00:00- HK$2.94bn
- HK$2.99bn
- CNY38.25m
Brief: Impact Therapeutics Says CEO Purchases 100,000 Ordinary Shares At HK$14.6105 Per Share
Brief: IMPACT Therapeutics Signs Exclusive License Deal With Pharmanovia For Senaparib In Europe, Others
Metis TechBio, IMPACT Therapeutics shine in Hong Kong debut
Brief: Impact Therapeutics Says Final Offer Price Under Global Offering Of Hk$20.10 Per H Share